Prev Close | 43.72 |
Day Low/High | 43.53 / 44.69 |
52 Wk Low/High | 24.30 / 43.89 |
Prev Close | 43.72 |
Day Low/High | 43.53 / 44.69 |
52 Wk Low/High | 24.30 / 43.89 |
Exchange | NASDAQ |
Shares Outstanding | 99.46B |
Market Cap | 4.35B |
P/E Ratio | N/A |
Div & Yield | N.A. (N.A) |
Avnet insiders have been buying up shares.
The list is dominated by retailers, of which there are four; that's unfortunate, given the pressure that sector is facing these days.
An eclectic mix of 20 companies made my cut of stocks trading at 1x to 2x net current asset value.
The electronic components name that recently bought Premier Farnell is undergoing a noteworthy transition.
Checking the gauges for underperformance, none of them look good.
This is what matters in making more money for your portfolio.
Jim Cramer, The Street's Action Alerts PLUS Portfolio Manager and host of CNBC's 'Mad Money,' said Allergan (AGN) is a stock to hold onto.
'Old' tech is coming on strong.
It's discounting who needs to be discounted.
An immense market rotation is happening.
These stocks have seen such spikes in concert with price compression, which tends to amplify volatility.
The EU recovery has put heavily exposed U.S. techs and industrials in an enviable position.
Right as the U.S. becomes worse for business.
Dan Fitzpatrick, founder of StockMarketMentor.com, details three stocks Jim Cramer discussed on CNBC's "Mad Money" and how to trade them.
Sure is plenty of bad but there is good afoot, too.
As we have seen time and again, weakness really is a buying opportunity.
We're right in the tech sweet spot and it sure isn't happening.
Though we are seeing a mixed picture, it is leading to higher prices.
Are things so bad in the space that we have to buy it?
Electronic-equipment names are hot, and these three stocks are looking especially solid.
The group is higher, yes, but there's a lot of life left in this move.
The biggest surprise of 2012 could be that the financials, the most hated group out there, can actually soar.
The market won't be in the clear until we see some institutional buying. Plus, my weekly model portfolio update.
It can't be great, but it can't be all bad.